We’ve got an important update! Over 60 organizations have signed an open letter addressing the need to improve access to life-saving treatments through the Medicines Patent Pool (MPP). We’re pushing to eliminate barriers for upper middle-income countries (UMICs) and ensure equitable access for all.
Reflecting on a decade of Dolutegravir (DTG), we’ve seen the remarkable impact it has on reducing HIV transmission and mortality. However, UMICs like Belarus, Kazakhstan, and Malaysia have faced delays and higher costs in accessing DTG. This highlights the need for transparency, robust competition, standard licensing, and active community involvement in future agreements with MPP.
Full text of the open letter below:
https://docs.google.com/document/d/12Yga1SiTQK9F3glrKFtjOyG3AFKQXi9i/edit
We’re still gathering signatures and eagerly await MPP’s response in a week. Let’s keep pushing for change and ensure no one is left behind in the fight against epidemics.
